GreenLight Biosciences Holdings Performance
| GRNAWDelisted Stock | USD 0.02 0 25.00% |
The company retains a Market Volatility (i.e., Beta) of 4.1, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, GreenLight Biosciences will likely underperform. GreenLight Biosciences right now retains a risk of 0.0%. Please check out GreenLight Biosciences jensen alpha, skewness, relative strength index, as well as the relationship between the value at risk and day median price , to decide if GreenLight Biosciences will be following its current trending patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days GreenLight Biosciences Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, GreenLight Biosciences is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 31.8 M |
GreenLight |
GreenLight Biosciences Relative Risk vs. Return Landscape
If you would invest 2.20 in GreenLight Biosciences Holdings on August 28, 2024 and sell it today you would earn a total of 0.00 from holding GreenLight Biosciences Holdings or generate 0.0% return on investment over 90 days. GreenLight Biosciences Holdings is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than GreenLight, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
GreenLight Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for GreenLight Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as GreenLight Biosciences Holdings, and traders can use it to determine the average amount a GreenLight Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| GRNAW |
Based on monthly moving average GreenLight Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GreenLight Biosciences by adding GreenLight Biosciences to a well-diversified portfolio.
GreenLight Biosciences Fundamentals Growth
GreenLight Stock prices reflect investors' perceptions of the future prospects and financial health of GreenLight Biosciences, and GreenLight Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GreenLight Stock performance.
| Revenue | 6.38 M | |||
| EBITDA | (153.99 M) | |||
| Cash And Equivalents | 34.75 M | |||
| Cash Per Share | 10.01 X | |||
| Total Debt | 80.48 M | |||
| Debt To Equity | 9.81 % | |||
| Book Value Per Share | (61.86) X | |||
| Cash Flow From Operations | (136.73 M) | |||
| Total Asset | 148.6 M | |||
| Retained Earnings | (420.64 M) | |||
About GreenLight Biosciences Performance
Evaluating GreenLight Biosciences' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if GreenLight Biosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if GreenLight Biosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid products for human health and agriculture applications. The company was founded in 2008 and is headquartered in Medford, Massachusetts. Greenlight Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 280 people.Things to note about GreenLight Biosciences performance evaluation
Checking the ongoing alerts about GreenLight Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for GreenLight Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| GreenLight Biosciences is not yet fully synchronised with the market data | |
| GreenLight Biosciences has some characteristics of a very speculative penny stock | |
| GreenLight Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 6.38 M. Net Loss for the year was (167.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| GreenLight Biosciences Holdings has accumulated about 34.75 M in cash with (136.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing GreenLight Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether GreenLight Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining GreenLight Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating GreenLight Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of GreenLight Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of GreenLight Biosciences' stock. These opinions can provide insight into GreenLight Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in GreenLight Stock
If you are still planning to invest in GreenLight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GreenLight Biosciences' history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets |